SCHEMBL7354479

SCHEMBL7354479

c1cnc2ccc3cc(-c4ncc[nH]4)[nH]c3c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 2/20 0.41
CYP19A1 P11511 1/20 0.37
MTOR P42345 1/20 0.36
ADK P55263 1/20 0.36
NISCH Q9Y2I1 1/20 0.36
ADRA2A P08913 2/20 0.35
NPC1 O15118 2/20 0.35
ALDH1A1 P00352 2/20 0.35
RAB9A P51151 2/20 0.35
DYRK1B Q9Y463 2/20 0.35
CSNK1A1 P48729 1/20 0.35
TYRO3 Q06418 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30538321 0.85 MAPT (0.52) CYP3A4KDM4EMAPTLMNACYP19A1
SCHEMBL7846153 0.81 CYP3A4 (0.47) CYP3A4KDM4EMAPTLMNACYP19A1
SCHEMBL10978833 0.78 CYP19A1 (0.58) CYP3A4KDM4EMAPTLMNACYP19A1
SCHEMBL31661367 0.73 CYP3A4 (0.49) CYP3A4KDM4EMAPTLMNACYP19A1
SCHEMBL27085550 0.73 CYP3A4 (0.49) CYP3A4KDM4EMAPTLMNACYP19A1
SCHEMBL28329118 0.73 RIPK1 (0.54)
SCHEMBL17786644 0.71 LMNA (0.54) CYP3A4KDM4EMAPTLMNAMTOR
SCHEMBL11219318 0.71 HSD17B10 (0.63) CYP3A4KDM4EMAPTLMNACYP19A1
SCHEMBL2653873 0.71 KDM4E (0.47) KDM4EMAPTMTORADKNISCH
SCHEMBL29852620 0.71 MAPT (0.54) CYP3A4KDM4EMAPTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575430-B1 PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE LUNDBECK & CO AS H (DK) 1998-08-05 EP disclosed
EP-0575429-B1 TREATMENT OF COGNITIVE DISORDERS LUNDBECK & CO AS H (DK) 1995-12-06 EP disclosed
US-5462948-A Treatment of addiction to drugs and substances of abuse H. LUNDBECK A/S (DK) 1995-10-31 US disclosed
US-5444073-A Administering 1-aryl-3-(4-piperidyl)-indole derivatives H. LUNDBECK A/S (DK) 1995-08-22 US disclosed
EP-0575429-A1 TREATMENT OF COGNITIVE DISORDERS. LUNDBECK & CO AS H (DK) 1993-12-29 EP disclosed
EP-0575430-A1 PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE H. LUNDBECK A/S (DK) 1993-12-29 EP disclosed
WO-1992015302-A1 TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE H. LUNDBECK A/S (DK) 1992-09-17 WO disclosed
WO-1992015303-A1 TREATMENT OF COGNITIVE DISORDERS H. LUNDBECK A/S (DK) 1992-09-17 WO disclosed